Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report

BACKGROUND: Tocilizumab is a humanized monoclonal antibody that acts as an IL-6 receptor antagonist. Intravenous tocilizumab is considered an option for children with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis. In contrast, the potential of subcutaneous drug use with this i...

Descripción completa

Detalles Bibliográficos
Autores principales: Burlo, Francesca, Tumminelli, Cristina, Pastore, Serena, Stocco, Gabriele, Curci, Debora, Lucafò, Marianna, Tommasini, Alberto, Taddio, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496382/
https://www.ncbi.nlm.nih.gov/pubmed/37700264
http://dx.doi.org/10.1186/s12969-023-00883-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496382/
https://www.ncbi.nlm.nih.gov/pubmed/37700264
http://dx.doi.org/10.1186/s12969-023-00883-y

Ejemplares similares